# EB5 Life Sciences

EB5 Life Sciences is an Asset Manager based in San Francisco, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** San Francisco, United States
- **Region:** North America
- **Address:** San Francisco, California, United States
- **Founded:** 2009
- **Assets under management:** Undisclosed
- **Website:** eb5lifesciences.com

## Regulatory record

- **Reports private funds:** No

## About

David Tieh, a real estate attorney and former U.S. Army officer, launched EB5 Life Sciences in 2009 to connect EB-5 visa investors with life-science infrastructure projects. The firm operates at the intersection of real estate development and healthcare, targeting properties that serve biotech, pharmaceutical, and clinical research tenants — including wet labs, medical office buildings, and drug manufacturing facilities. Wealth origin is not publicly disclosed for the firm's principals. EB5 Life Sciences structures its capital raising through regional centers designated under the federal EB-5 Immigrant Investor Program. The firm oversees the entire process — from identifying projects and securing government approval to placing foreign capital into job-creating ventures. Asset classes include life-science real estate (lab and office space), pharmaceutical manufacturing facilities, and clinical-stage company infrastructure. The firm has cited funded projects such as the BioMed Realty portfolio in San Diego and a life-sciences campus near the University of California, San Francisco — both structured to qualify for EB-5 designation (per public EB-5 project listings, 2020). The firm's total deployment or team size is not publicly available. EB5 Life Sciences operates largely from its San Francisco base. The firm has not disclosed additional offices. No philanthropic or operating-company arms are known. A recent operational marker: in early 2023, the firm continued to list active EB-5 projects in life science real estate bonds and construction loans, per the U.S. Citizenship and Immigration Services regional center pages. EB5 Life Sciences' structural differentiator is its narrow focus on EB-5 visa-driven capital for life-science real estate — a niche that requires both immigration-law expertise and life-science asset knowledge. The firm operates as a project sponsor and regional center operator, not as a traditional real estate fund manager, giving it a regulatory moat tied to federal visa policy.

## Sectors

- Life Sciences
- Biotech
- Pharmaceuticals
- Healthcare Services
- Real Estate

## People

- David Tieh — Founder & CEO
- Angela Tieh — Chief Operating Officer

## Questions

### Who runs investment decisions at EB5 Life Sciences?

David Tieh, the founder and CEO, controls investment strategy. He is a real estate attorney and former U.S. Army officer. Angela Tieh serves as Chief Operating Officer. Both are listed in public SEC filings.

### How does EB5 Life Sciences source proprietary deal flow?

The firm identifies life-science real estate projects — labs, medical offices, drug manufacturing plants — that meet EB-5 visa job-creation requirements. They work with developers and tenants in biotech hubs such as San Diego and San Francisco.

### Does EB5 Life Sciences participate in fund commitments or only direct deals?

The firm sponsors specific project-level EB-5 funds rather than open-end pooled vehicles. Each project is structured as a separate limited partnership that qualifies for the EB-5 program.

### What investment stages does EB5 Life Sciences typically target?

The firm focuses on development-stage and construction-stage life-science real estate. Projects include new lab buildings, medical office conversions, and pharmaceutical facility expansions.

### Which sectors does EB5 Life Sciences explicitly avoid?

The firm avoids non-life-science real estate such as retail, hospitality, residential, and traditional office space. Its mandate is tied to healthcare and biotech infrastructure.

## Related profiles

- [Stoneway Capital](https://altss.com/profile/stoneway-capital)
- [Wandai Capital](https://altss.com/profile/wandai-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/eb5-life-sciences

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology